Latest News & Features
Big Pharma
Amgen and two research centres have thrown their support behind Bristol Myers Squibb subsidiary Juno Therapeutics to help restore a $1.1 billion patent judgment against Kite Pharma that was overturned by the US Court of Appeals for the Federal Circuit. 16 November 2021
Big Pharma
The US Patent Trial and Appeal Board will review the validity of two Regeneron Pharmaceuticals patents related to its Eylea (aflibercept) medication. 11 November 2021
article
The Federal Trade Commission has stipulated that generic drug marketers ANI Pharmaceuticals, and Novitium Pharma must divest IP rights to Prasco ahead of their $210 million merger. 11 November 2021
Americas
Moderna is facing accusations from the US National Institute of Health that it failed to give due recognition to three scientists as inventors on its COVID-19 vaccine application. 11 November 2021
Asia
The China National Intellectual Property Administration has accepted its first set of drug patent linkage complaints since the introduction of a new patent law in June 2021. 9 November 2021
Medtech
Qiagen will pay Becton, Dickinson $53 million to settle an ongoing patent infringement lawsuit over polymerase chain reaction diagnostics patents. 9 November 2021
Big Pharma
Novartis yesterday, November 4, announced that it is selling its entire stake in Roche—equating to 53.3 million bearer shares—back to the Swiss healthcare company for the sum of $20.7 billion. 5 November 2021
article
The 1999 Japanese Supreme Court judgment in the case of Ono Pharmaceuticals Co Ltd vs Kyoto Pharmaceutical Industries Ltd, held that carrying out necessary experiments to apply for approval of generic drugs stipulated in article 14 of the Pharmaceutical Affairs Act falls within “working of the patented invention for experiment or research”, however the original drugs are not mentioned. 4 November 2021
Americas
Wholesale buyers of the cholesterol treatment Zetia have won the backing of a US judge for their market definition in an antitrust suit against MSD and Glenmark. 4 November 2021
Generics
Following two-day oral proceedings at the Munich Board of Appeal of the European Patent Office, the court has upheld the validity of a Bayer Pharmaceuticals’ dosing patent for Xarelto. 4 November 2021